Ding Dale, Xu Zhiyuan, Yen Chun-Po, Starke Robert M, Sheehan Jason P
Department of Neurological Surgery, University of Virginia, Charlottesville, Virginia, USA.
Department of Neurological Surgery, University of Virginia, Charlottesville, Virginia, USA.
World Neurosurg. 2015 Sep;84(3):795-804. doi: 10.1016/j.wneu.2015.05.012. Epub 2015 May 18.
Cerebral arteriovenous malformations (AVM) are infrequently diagnosed and treated in elderly patients (age, >60 years). We hypothesize that, in contrast to AVM surgical outcomes, radiosurgery outcomes are not adversely affected by increased age. The goals of this case-control study are to analyze the radiosurgery outcomes for elderly patients with AVMs and determine the effect of elderly age on AVM radiosurgery outcomes.
We evaluated a prospective database of patients with AVMs treated with radiosurgery from 1989 to 2013. Elderly patients with AVM (age, ≥ 60 years) with radiologic follow-up of ≥ 2 years or nidus obliteration were selected for analysis, and matched, in a 1:1 fashion and blinded to outcome, to adult nonelderly patients with AVM (age, <60 years). Statistical analyses were performed to determine actuarial obliteration rates and evaluate the relationship between elderly age and AVM radiosurgery outcomes.
The matching processes yielded 66 patients in each of the elderly and nonelderly AVM cohorts. In the elderly AVM cohort, the actuarial AVM obliteration rates at 3, 5, and 10 years were 37%, 65%, and 77%, respectively; the rates of radiologically evident, symptomatic, and permanent radiation-induced changes were 36%, 11%, and 0%, respectively; the annual hemorrhage risk after radiosurgery was 1.1%, and the AVM-related mortality rate was 1.5%. Elderly age was not significantly associated with AVM obliteration, radiation-induced changes, or hemorrhage after radiosurgery.
Advanced age does not appear to confer appreciably worse AVM radiosurgery outcomes, unlike its negative effect on AVM surgical outcomes. Thus, when an AVM warrants treatment, radiosurgery may be the preferred treatment for elderly patients.
脑动静脉畸形(AVM)在老年患者(年龄>60岁)中很少被诊断和治疗。我们假设,与AVM手术结果不同,放射外科治疗结果不会因年龄增加而受到不利影响。本病例对照研究的目的是分析老年AVM患者的放射外科治疗结果,并确定老年对AVM放射外科治疗结果的影响。
我们评估了1989年至2013年接受放射外科治疗的AVM患者的前瞻性数据库。选择年龄≥60岁且放射学随访≥2年或病灶闭塞的老年AVM患者进行分析,并以1:1的方式与成年非老年AVM患者(年龄<60岁)进行匹配,且对结果设盲。进行统计分析以确定精算闭塞率,并评估老年与AVM放射外科治疗结果之间的关系。
匹配过程在老年和非老年AVM队列中各产生了66例患者。在老年AVM队列中,3年、5年和10年的精算AVM闭塞率分别为37%、65%和77%;放射学明显改变、有症状改变和永久性放射诱发改变的发生率分别为36%、11%和0%;放射外科治疗后的年出血风险为1.1%,AVM相关死亡率为1.5%。年龄较大与放射外科治疗后AVM闭塞、放射诱发改变或出血无显著相关性。
与年龄增长对AVM手术结果的负面影响不同,高龄似乎不会使AVM放射外科治疗结果明显更差。因此,当AVM需要治疗时,放射外科可能是老年患者的首选治疗方法。